Health authorities warn against potential serious risks of hair-loss drug

Health regulators in both the United States and Europe are issuing warnings about the potential health risks associated with finasteride, a popular hair-loss drug. The European Medicines Agency recently confirmed suicidal thoughts as a side effect of finasteride tablets, leading to the implementation of new measures to protect the public. Similarly, U.S. health regulators have warned against sexual dysfunction and depression linked to topical finasteride, a newer version of the medication applied directly to the skin.

The FDA emphasized that there is no approved topical formulation of finasteride, and the safety and quality of these products have not been evaluated. Despite its popularity, topical finasteride has never been approved in Canada either. The pill version, known as Propecia, has been on the market for 30 years and is approved by the FDA and Health Canada.

Recent investigations have shed light on the rare but serious side effects of finasteride, with reports of adverse reactions including anxiety, depression, decreased libido, and erectile dysfunction. Many men have turned to topical finasteride in hopes of experiencing fewer side effects than the oral version, only to discover similar debilitating symptoms.

In Canada, the illegal marketing of topical finasteride is a growing concern. While compounded preparations are permitted for individual use, mass production and advertising of these drugs are prohibited. Despite these regulations, many Canadian websites openly promote topical finasteride, often without disclosing its lack of approval by Health Canada.

Telemedicine platforms have also come under scrutiny for providing rushed and superficial medical consultations, with limited information about the risks associated with finasteride. Health Canada has received complaints about the sale and advertising of finasteride-based products, leading to regulatory actions against some companies.

Overall, the warnings from health regulators serve as a reminder of the potential risks associated with finasteride, whether in pill or topical form. It is essential for individuals to be informed about the medications they are using and to consult healthcare professionals before starting any new treatment.